These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2892853

  • 1. Functional opioid receptor sites in human placentas.
    Belisle S, Petit A, Gallo-Payet N, Bellabarba D, Lehoux JG, Lemaire S.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):283-9. PubMed ID: 2892853
    [Abstract] [Full Text] [Related]

  • 2. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [Abstract] [Full Text] [Related]

  • 3. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
    Fedynyshyn JP, Kwiat G, Lee NM.
    Eur J Pharmacol; 1989 Jan 02; 159(1):83-8. PubMed ID: 2540013
    [Abstract] [Full Text] [Related]

  • 4. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW, Liu-Chen LY.
    J Pharmacol Exp Ther; 1986 Nov 02; 239(2):351-7. PubMed ID: 3021954
    [Abstract] [Full Text] [Related]

  • 5. Purification of a kappa-opioid receptor subtype from frog brain.
    Simon J, Benyhe S, Hepp J, Khan A, Borsodi A, Szücs M, Medzihradszky K, Wollemann M.
    Neuropeptides; 1987 Jul 02; 10(1):19-28. PubMed ID: 2890119
    [Abstract] [Full Text] [Related]

  • 6. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL, Brown SR, Puttfarcken P, Cox BM.
    Mol Pharmacol; 1986 Aug 02; 30(2):90-5. PubMed ID: 3016504
    [Abstract] [Full Text] [Related]

  • 7. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL, Zarr GD, Brown SR, Cox BM.
    J Pharmacol Exp Ther; 1985 Jun 02; 233(3):722-8. PubMed ID: 2989494
    [Abstract] [Full Text] [Related]

  • 8. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B, Rajpara A, O'Connor LH, Cicero TJ.
    Life Sci; 1988 Jun 02; 42(23):2403-12. PubMed ID: 2836684
    [Abstract] [Full Text] [Related]

  • 9. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J, Sánchez-Blázquez P, Lee NM.
    J Pharmacol Exp Ther; 1984 Oct 02; 231(1):33-7. PubMed ID: 6092603
    [Abstract] [Full Text] [Related]

  • 10. Evidence for mu-, delta-, and kappa-opioid receptors in a human neuroblastoma cell line.
    Baumhaker Y, Wollman Y, Goldstein MN, Sarne Y.
    Life Sci; 1993 Oct 02; 52(19):PL205-10. PubMed ID: 8387137
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S, Bhargava HN.
    Neuropharmacology; 1987 Aug 02; 26(8):1141-6. PubMed ID: 2889163
    [Abstract] [Full Text] [Related]

  • 12. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P, Werling LL, Brown SR, Cote TE, Cox BM.
    Mol Pharmacol; 1986 Aug 02; 30(2):81-9. PubMed ID: 3016503
    [Abstract] [Full Text] [Related]

  • 13. Affinities of some common opioid analgesics towards four binding sites in mouse brain.
    Neil A.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov 02; 328(1):24-9. PubMed ID: 6151117
    [Abstract] [Full Text] [Related]

  • 14. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
    Fischel SV, Medzihradsky F.
    Neuropharmacology; 1986 Apr 02; 25(4):351-9. PubMed ID: 3012397
    [Abstract] [Full Text] [Related]

  • 15. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
    Clark JA, Liu L, Price M, Hersh B, Edelson M, Pasternak GW.
    J Pharmacol Exp Ther; 1989 Nov 02; 251(2):461-8. PubMed ID: 2553920
    [Abstract] [Full Text] [Related]

  • 16. Modulation of mu, delta and kappa opioid receptors in rat brain by metal ions and histidine.
    Tejwani GA, Hanissian SH.
    Neuropharmacology; 1990 May 02; 29(5):445-52. PubMed ID: 2162496
    [Abstract] [Full Text] [Related]

  • 17. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J, Luo LY, Li JG, Chen C, Liu-Chen LY.
    J Pharmacol Exp Ther; 1997 Aug 02; 282(2):676-84. PubMed ID: 9262330
    [Abstract] [Full Text] [Related]

  • 18. Developmental pattern of opioid receptors in the striatum and hippocampus: evidence for a non-mature type of receptor in embryonic tissue.
    Barg J, Hatini V, Simantov R.
    Prog Clin Biol Res; 1990 Aug 02; 328():141-4. PubMed ID: 2154769
    [No Abstract] [Full Text] [Related]

  • 19. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul 02; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 20. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
    Gué M, Junien JL, Bueno L.
    J Pharmacol Exp Ther; 1989 Sep 02; 250(3):1006-10. PubMed ID: 2550612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.